TETRAPHASE PHARMACEUTICALS I's ticker is TTPHXXXX and the CUSIP is 88165N105. A total of 68 filers reported holding TETRAPHASE PHARMACEUTICALS I in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $1,000 | -50.0% | 1,150 | 0.0% | 0.00% | – |
| Q1 2019 | $2,000 | +100.0% | 1,150 | 0.0% | 0.00% | – |
| Q4 2018 | $1,000 | -94.4% | 1,150 | -82.3% | 0.00% | – |
| Q3 2018 | $18,000 | +100.0% | 6,500 | +160.0% | 0.00% | – |
| Q2 2018 | $9,000 | +12.5% | 2,500 | 0.0% | 0.00% | – |
| Q1 2018 | $8,000 | -50.0% | 2,500 | 0.0% | 0.00% | – |
| Q4 2017 | $16,000 | -5.9% | 2,500 | 0.0% | 0.00% | – |
| Q3 2017 | $17,000 | -5.6% | 2,500 | 0.0% | 0.00% | – |
| Q2 2017 | $18,000 | -21.7% | 2,500 | 0.0% | 0.00% | – |
| Q1 2017 | $23,000 | +360.0% | 2,500 | +87.4% | 0.00% | – |
| Q3 2016 | $5,000 | 0.0% | 1,334 | 0.0% | 0.00% | – |
| Q2 2016 | $5,000 | – | 1,334 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARVEY CAPITAL MANAGEMENT INC | 293,675 | $14,061,000 | 4.76% |
| BB BIOTECH AG | 1,507,114 | $71,497,000 | 1.94% |
| SECTORAL ASSET MANAGEMENT INC | 893,076 | $42,368,000 | 1.77% |
| Opaleye Management Inc. | 65,000 | $3,084,000 | 1.23% |
| COLUMBIA PARTNERS L.L.C. INVESTMENT MANAGEMENT | 390,294 | $18,515,000 | 1.14% |
| Granite Point Capital Management, L.P. | 75,206 | $3,568,000 | 1.04% |
| Granahan Investment Management | 705,601 | $33,474,000 | 0.95% |
| Iguana Healthcare Management, LLC | 50,000 | $2,372,000 | 0.75% |
| Eventide Asset Management | 290,000 | $13,758,000 | 0.74% |
| Rhenman & Partners Asset Management AB | 107,400 | $5,095,000 | 0.61% |